Posted on 8/8/18
Pfizer: The Outlook Cannot Justify Current Valuation
SummaryPfizer is currently trading at a ~20% discount rate, when taking into account discounted cash flows as well as a multiples analysis.Current estimates of a -5% . . .
Posted on 7/6/18
Verizon: Make The Call And Add This Undervalued Telecom Giant To Your Portfolio
According to my discounted cash flow model, Verizon Communication Inc. (NYSE:VZ) is currently 40% undervalued and this is supported via a multiples analysis. Despite uncertainty in . . .
Posted on 6/21/18
Johnson & Johnson: Strong Company, But Won't Fit In Most Portfolios
Johnson & Johnson (NYSE:JNJ) is a company with strong financial health and a lot of cash is currently being held for future acquisitions. JNJ is only . . .
New York
